www.fdanews.com/articles/87695-receptopharm-signs-letter-of-intent-to-be-aquired-by-nutra-pharma-corporation
RECEPTOPHARM SIGNS LETTER OF INTENT TO BE AQUIRED BY NUTRA PHARMA CORPORATION
June 19, 2006
Nutra Pharma Corp., a biotechnology company that is developing drugs for HIV and Multiple Sclerosis has announced that ReceptoPharm has signed a letter of intent to be fully acquired by Nutra Pharma Corp.
Genetic
Engineering News